Theravance Biopharma Inc Sustainability Reports
Theravance Biopharma, Inc. is a biopharmaceutical company primarily focused on the discovery, development, and commercialization of organ-selective medicines. Its portfolio includes respiratory therapeutics such as YUPELRI (revefenacin) inhalation solution.
Sector: Manufacturing
Country: Cayman Islands
Exchange: Nasdaq
LEI: 5493007VTSXP4Z6MIW52
FIGI: BBG004HK6YY0
4 reports from 2017 to 2022
